| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/01/2001 | WO2001007611A2 Novel polynucleotides and method for the use thereof |
| 02/01/2001 | WO2001007610A1 Pmf-1 (polyamide-modulated factor 1) |
| 02/01/2001 | WO2001007609A1 Axor39, a g-protein coupled receptor with 7-tm segments |
| 02/01/2001 | WO2001007608A1 Keratinocyte derived interferon |
| 02/01/2001 | WO2001007607A2 FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY |
| 02/01/2001 | WO2001007606A1 Axor21, a g-protein coupled receptor |
| 02/01/2001 | WO2001007605A1 Immunosuppression by cell surface expression of recombinant cd154 |
| 02/01/2001 | WO2001007604A1 Isolated peptide of the horny layer and use thereof |
| 02/01/2001 | WO2001007603A1 Cloning of nps45: a gene encoding a putative translation initiation/stabilization factor |
| 02/01/2001 | WO2001007602A2 Oligonucleotides for inhibiting the expression of human eg5 |
| 02/01/2001 | WO2001007601A2 Method for conferring herbicide, pest, or disease resistance in plant hosts |
| 02/01/2001 | WO2001007600A1 Method of correlating sequence function by transfecting a nucleic acid sequence of a donor organism into a plant host in an anti-sense or positive sense orientation |
| 02/01/2001 | WO2001007599A1 Method for rnase- and organic solvent-free plasmid dna purification using tangential flow filtration |
| 02/01/2001 | WO2001007598A1 EXPRESSION CLONING USING A TAGGED cDNA LIBRARY |
| 02/01/2001 | WO2001007597A1 Chromatographic process for purifying plasmid dna using superporous supports |
| 02/01/2001 | WO2001007596A1 Arabidopsis thaliana cyclic nucleotide-gated ion channel/dnd genes; regulators of plant disease resistance and cell death |
| 02/01/2001 | WO2001007595A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | WO2001007594A1 Antisense modulation of mekk1 expression |
| 02/01/2001 | WO2001007592A2 Herbicide resistant plants and methods for the production thereof |
| 02/01/2001 | WO2001007591A2 Dna sequences which code export systems |
| 02/01/2001 | WO2001007590A2 Chimeric genes for plastid expression |
| 02/01/2001 | WO2001007589A2 Dna sequences encoding lipopeptide synthases |
| 02/01/2001 | WO2001007588A2 Dna sequences which code nodulation factors |
| 02/01/2001 | WO2001007587A2 Dna sequences coding for iron and heavy metal transporters |
| 02/01/2001 | WO2001007585A1 Electrical impedance tomography to control electroporation |
| 02/01/2001 | WO2001007584A1 Controlled electroporation and mass transfer across cell membranes |
| 02/01/2001 | WO2001007583A1 Cell/tissue analysis via controlled electroporation |
| 02/01/2001 | WO2001007578A2 Subtilisin protease variants having amino acid substitutions in defined epitope regions |
| 02/01/2001 | WO2001007575A2 Subtilisin protease variants having amino acid deletions and substitutions in defined epitope regions |
| 02/01/2001 | WO2001007574A2 Modified cytochrome p450 monooxygenases |
| 02/01/2001 | WO2001007573A1 Electron donor system for enzymes and its use for the biochemical conversion of substrates |
| 02/01/2001 | WO2001007572A2 Dna recombination in eukaryotic cells by the bacteriophage phic31 recombination system |
| 02/01/2001 | WO2001007571A1 Means and methods for nucleic acid transfer |
| 02/01/2001 | WO2001007570A1 Regulation of source-sink relationships and responses to stress conditions in plants |
| 02/01/2001 | WO2001007568A2 Muscle cells and their use in cardiac repair |
| 02/01/2001 | WO2001007567A1 Engineering of metabolic control |
| 02/01/2001 | WO2001007566A2 Phage-resistant microorganisms and genetic determinants of phage resistance |
| 02/01/2001 | WO2001007565A2 Monoterpene synthases from grand fir (abies grandis) |
| 02/01/2001 | WO2001007484A2 Protease conjugates having sterically protected clip sites |
| 02/01/2001 | WO2001007483A1 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 02/01/2001 | WO2001007482A1 Gpr27, a g-protein coupled receptor |
| 02/01/2001 | WO2001007481A1 Antitumor antibodies, proteins, and uses thereof |
| 02/01/2001 | WO2001007479A2 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
| 02/01/2001 | WO2001007478A1 A p1 artificial chromosome (pac) vector for the expression of pituitary adenyl cyclase activating peptide receptor (pacap receptor) and transgenic animals comprising said vector |
| 02/01/2001 | WO2001007476A1 26 human prostate and prostate cancer associated proteins |
| 02/01/2001 | WO2001007475A1 Novel peptides |
| 02/01/2001 | WO2001007472A1 Highly purified cytokine activating factor and methods of use |
| 02/01/2001 | WO2001007471A2 Cell cycle and proliferation proteins |
| 02/01/2001 | WO2001007470A2 Human nervous system-associated proteins |
| 02/01/2001 | WO2001007466A1 Kinase blocking polypeptides and uses thereof |
| 02/01/2001 | WO2001007461A1 Antisense modulation of mekk5 expression |
| 02/01/2001 | WO2001007459A1 29 human secreted proteins |
| 02/01/2001 | WO2001007457A1 Antisense modulation of pten expression |
| 02/01/2001 | WO2001007456A1 Antisense modulation of jun n-terminal kinase kinase-1 expression |
| 02/01/2001 | WO2001007452A1 Extraction of nucleic acids |
| 02/01/2001 | WO2001007451A2 Isolation of biomolecules |
| 02/01/2001 | WO2001007159A2 Integration of biochemical protocols in a continuous flow microfluidic device |
| 02/01/2001 | WO2001007088A2 Methods for treating therapy-resistant tumors |
| 02/01/2001 | WO2001007084A1 Anti-growth factor receptor avidin fusion proteins as universal vectors for drug delivery |
| 02/01/2001 | WO2001007081A1 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 02/01/2001 | WO2001007074A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 02/01/2001 | WO2001007072A1 Modulation of platelet activation |
| 02/01/2001 | WO2001007066A2 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 02/01/2001 | WO2001007065A2 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 02/01/2001 | WO2001007055A1 Covalently closed immunostimulating nucleic acid molecule |
| 02/01/2001 | WO2001006989A2 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 02/01/2001 | WO2001006988A2 Super-active porcine growth hormone releasing hormone analog |
| 02/01/2001 | WO2001006849A1 Transgenic animal model for kaposi's sarcoma |
| 02/01/2001 | WO2001006848A1 Transgenic mice and overexpression model of the gene ntrk3 (trkc) based thereon for the study and monitoring of treatments of anxiety, depression and related psychiatric diseases |
| 02/01/2001 | WO2001006844A1 Method for superrapid transformation of monocotyledon |
| 02/01/2001 | WO2000067558B1 Regulation of gene expression in tobacco for manipulation of plant growth and secondary metabolism |
| 02/01/2001 | WO2000066722B1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 02/01/2001 | WO2000066720A3 The use of adeno-associated virus (aav) deliver cytoprotective genes |
| 02/01/2001 | WO2000063397A3 Methods for delivering inhibitory rna to plants and applications thereof |
| 02/01/2001 | WO2000063352A3 Human homologues of fused gene |
| 02/01/2001 | WO2000061736A3 Recombinant and mutant marek's disease virus |
| 02/01/2001 | WO2000061728A3 Human elastase i |
| 02/01/2001 | WO2000061727A3 Production of pancreatic procarboxy-peptidase b, isoforms and muteins thereof, and their use |
| 02/01/2001 | WO2000061724A3 Anti-bacterial vaccine compositions |
| 02/01/2001 | WO2000060095A3 Enzymes of the biosynthetic pathway for the production of triacylglycerol and recombinant dna molecules encoding these enzymes |
| 02/01/2001 | WO2000059917A3 Information-carrying and information-processing polymers |
| 02/01/2001 | WO2000058464A3 Rab genes and their uses |
| 02/01/2001 | WO2000056359A3 Vaccine against streptococcus pneumoniae |
| 02/01/2001 | WO2000053756A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/01/2001 | WO2000053742A3 Polynucleotides and proteins encoded thereby |
| 02/01/2001 | WO2000053733A3 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 02/01/2001 | WO2000053161A3 Microparticles for delivery of nucleic acid |
| 02/01/2001 | WO2000052047A3 Human dickkopf-related protein and nucleic acid molecules and uses therefor |
| 02/01/2001 | WO2000049043A3 Human lipid-associated proteins |
| 02/01/2001 | WO2000044906A3 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI) |
| 02/01/2001 | WO2000043781A3 Growth differentiation factor inhibitors and uses therefor |
| 02/01/2001 | WO2000037493A3 Type iii secretion system antigens from bordetella pertussis |
| 02/01/2001 | WO2000024772A3 Scorpion toxins |
| 02/01/2001 | WO2000015838A3 Essential genes from c. albicans and a method for screening antimycotic substances using said genes |
| 02/01/2001 | WO2000009668A9 Engraftable human neural stem cells |
| 02/01/2001 | WO2000008138A3 Ribosomal rna (rrn) operon altered bacteria and uses thereof |
| 02/01/2001 | WO2000008041A9 Structural analogs of amine bases and nucleosides |
| 02/01/2001 | WO2000006715A9 Automatic eukaryotic artificial chromosome vector |
| 02/01/2001 | WO1999065461A9 Cationic amphiphile micellar complexes |
| 02/01/2001 | WO1999041376A9 Retinoblastoma protein complexes and retinoblastoma interacting proteins |